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The Pseudomonas aeruginosa toxin L-2-amino-4-methoxy-trans-3-butenoic acid (AMB) is a
non-proteinogenic amino acid which is toxic for prokaryotes and eukaryotes. Production of
AMB requires a ﬁve-gene cluster encoding a putative LysE-type transporter (AmbA), two
non-ribosomal peptide synthetases (AmbB and AmbE), and two iron(II)/α-ketoglutarate-
dependent oxygenases (AmbC and AmbD). Bioinformatics analysis predicts one thiolation
(T) domain for AmbB and two T domains (T1 and T2) for AmbE, suggesting that AMB is
generated by a processing step from a precursor tripeptide assembled on a thiotemplate.
Using a combination of ATP-PPi exchange assays, aminoacylation assays, and mass
spectrometry-based analysis of enzyme-bound substrates and pathway intermediates, the
AmbB substrate was identiﬁed to be L-alanine (L-Ala), while the T1 and T2 domains of
AmbE were loaded with L-glutamate (L-Glu) and L-Ala, respectively. Loading of L-Ala at T2
of AmbE occurred only in the presence of AmbB, indicative of a trans loading mechanism.
In vitro assays performed with AmbB and AmbE revealed the dipeptide L-Glu-L-Ala at T1
and the tripeptide L-Ala-L-Glu-L-Ala attached atT2.When AmbC and AmbDwere included in
the assay, these peptides were no longer detected. Instead, an L-Ala-AMB-L-Ala tripeptide
was found at T2. These data are in agreement with a biosynthetic model in which L-Glu is
converted into AMB by the action of AmbC, AmbD, and tailoring domains of AmbE. The
importance of the ﬂanking L-Ala residues in the precursor tripeptide is discussed.
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INTRODUCTION
Pseudomonas aeruginosa is an opportunistic pathogen often affect-
ing patients who suffer from compromised antimicrobial bar-
riers, as for instance the genetic disease cystic ﬁbrosis (Lyczak
et al., 2002). One of the many toxins that this bacterium pro-
duces is L-2-amino-4-methoxy-trans-3-butenoic acid (AMB), a
non-proteinogenic amino acid belonging to a small group of
natural compounds known as oxyvinylglycines (Berkowitz et al.,
2006). Other members of this group are aminoethoxyvinylglycine
(AVG), dimethyliminooxyvinylglycine, and guanidinooxyvinyl-
glycine from Streptomyces spp. (Pruess et al., 1974; Hirata et al.,
1993), rhizobitoxin made by Bradyrhizobium japonicum and P.
andropogonis (Owens et al., 1972; Mitchell et al., 1986), as well
as the recently identiﬁed 4-formylaminooxyvinylglycine (FVG)
isolated from P. ﬂuorescens WH6 (McPhail et al., 2010). Oxyvinyl-
glycines irreversibly inhibit pyridoxal phosphate (PLP)-dependent
enzymes and thus have multiple targets in bacteria, animals, and
plants (Berkowitz et al., 2006). A prominent plant target is the
ethylene biosynthesis enzyme ACC synthase, which is inhibited
by AVG. Commercially available under the name of Retain®, AVG
is widely used for the regulation of fruit set in orchard crops.
Another example with potential for an agricultural application is
FVG. This oxyvinylglycine is a natural herbicide which blocks the
germination of a large variety of grassy weed species (Banowetz
et al., 2008).
Pyridoxal phosphate-dependent enzymes are also targeted by
AMB. Isolated originally as a growth inhibitor of Bacillus subtilis
(Scannell et al., 1972) and Escherichia coli (Sahm et al., 1973),
AMB was shown to inhibit apartate aminotransferase in pigs
(Rando, 1974; Rando et al., 1976) and rat hepatocytes (Smith
and Freeland, 1981; Cornell et al., 1984), tryptophane synthase
in E. coli (Miles, 1975), δ-aminolevulinic acid synthetase in
rats (Dashman and Kamm, 1979), and serine hydroxylmethyl
transferase in Walker carcinoma (Tisdale, 1981). Reversible inhi-
bition of L-methionine tRNA aminoacylation was also reported,
suggesting that AMB can function as a methionine antimetabo-
lite (Matoo et al., 1979). We recently evaluated the importance
of AMB as a P. aeruginosa virulence factor using an Acan-
thamoeba castellanii cell model (Lee et al., 2012). Although
AMB was found to inhibit growth and to induce cyst forma-
tion, the effective concentrations were rather high, making a
strong contribution of AMB to the virulence of P. aeruginosa
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unlikely. AMB may be more important during interactions of
P. aeruginosa with other microbes and it is interesting to note
in this respect that AMB can inhibit the growth of impor-
tant plant and animal pathogens such as Erwinia amylovora
(Lee et al., 2013a) and Staphylococcus aureus (our unpublished
observation).
Transposon mutagenesis and reverse genetics have previously
led to the identiﬁcation of the P. aeruginosa ambABCDE gene
cluster which comprises two transcriptional units (Lee et al., 2010,
2013a; Figure 1). Transfer of this cluster to strains devoid of amb
genes, such as P. aeruginosa PA7, or P. ﬂuorescens CHA0, ren-
dered them capable of synthesizing AMB (Lee et al., 2010, 2013a),
demonstrating that these genes are both essential and sufﬁcient
for AMB production. Bioinformatics analyses indicate that the
ﬁrst transcriptional unit, ambA, encodes a putative LysE-type
transporter and may thus account for AMB secretion. The sec-
ond transcriptional unit speciﬁes four proteins predicted to be
involved in AMB biosynthesis. Two of these, AmbB and AmbE,
present the typical modular structure of non-ribosomal pep-
tide synthetases (NRPSs; Figure 1). The gene products of ambC
and ambD are predicted to belong to the family of iron(II)/α-
ketoglutarate-dependent oxygenases. Mostmembers of this family
catalyze hydroxylation of a substrate coupled to the oxidative
decarboxylation of an α-ketoglutarate cofactor using iron (II) as
the redox catalyst. However, other members also catalyze reac-
tions such as oxidative desaturation or cyclization (Hausinger,
2004).
Based on the observation that the Amb assembly line contains
three thiolation domains, (i.e., attachment points for amino acid
precursors, see Figure 1), we postulate that AMB biosynthesis
proceeds via a precursor tripeptide. Using in vitro methods and
analysis of enzyme-attached substrates and pathway intermedi-
ates by mass spectrometry (MS), we identiﬁed the building blocks
of AMB biosynthesis and we present a model of how the AMB
precursor tripeptide may be assembled.
MATERIALS AND METHODS
BACTERIAL STRAINS, PLASMIDS, AND CULTURE CONDITIONS
Strains and plasmids used in this study are listed in Table 1. Bac-
teria were routinely cultivated at 37◦C on nutrient agar and in
nutrient yeast broth (Stanisich and Holloway, 1972). To facilite
uptake of heterologous DNA during conjugation and transforma-
tion,P. aeruginosa was grown at 43◦C.When necessary, antibiotics
were added to the media of E. coli at the following concentrations:
ampicillin at 100 μg ml−1, chlorampheniol (Cm) at 30 μg ml−1,
kanamycin (Km), and tetracycline (Tc) at 25 μg ml−1 each. For
selection of Tc-resistant plasmids in P. aeruginosa, Tc was used
at 125 μg ml−1. Counterselection of E. coli donor cells during
mutant construction occurred with Cm at 10 μg ml−1; mutant
enrichment was performed with Tc at 20 μg ml−1 and carbeni-
cillin (Cb) at 2 mg ml−1. For protein puriﬁcation, cultures were
induced with isopropyl β-D-1-thiogalactopyranoside (IPTG) as
detailed below.
DNA MANIPULATIONS AND SEQUENCING
DNA manipulations were done according to standard procedures
(Sambrook and Russell, 2001). Plasmid DNA was prepared using
Jetstar (Genomed GmbH) and QIAprep Spin Miniprep (Qiagen,
Inc.) kits; DNA fragments were gel-puriﬁed with the Invisorb®
fragment cleanUp kit from Invitek. Bacterial transformations were
done by electroporation (Farinha and Kropinski, 1990). Con-
structs involvingPCR techniques (for oligonucleotides seeTable 2)
were veriﬁed by commercial sequence analysis carried out atGATC
Biotech.
CONSTRUCTION OF OVEREXPRESSION PLASMIDS FOR PROTEIN
PURIFICATION
For overexpression of ambB, the gene was PCR-ampliﬁed from
chromosomal DNA of PAO1 using the primer pair XL009/XL010.
The 3.8-kb PCR fragment was trimmed with NheI and EcoRI
and cloned between the same sites in pET-28a. This generated
FIGURE 1 | Organization of the amb gene cluster in the Pseudomonas
aeruginosa strain PAO1.The ambA gene encodes a putative LysE-type
transmembrane protein potentially involved in AMB export, ambB and ambE
code for non-ribosomal peptide synthetases (NRPS), and ambC and ambD
specify two putative iron (II)/α-ketoglutarate-dependent oxygenases. The
modular structures of AmbB and AmbE are shown with domains for
adenylation (A), thiolation (T), condensation (C), methylation (MT), and
thioester cleavage (TE). Note that AmbE may have an additional domain of
unknown function at its N-terminus and that the C domain (indicated as C*) is
atypical (see text for details).
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Table 1 | Bacterial strains and plasmids.
Name Relevant characteristics Reference/Source
Escherichia coli strains
BL21(DE3) F−, ompT, gal, dcm, lon, hsdSB (rB− mB−), λ(DE3) Novagen
BL21(DE3)/pLys F−, ompT, gal, dcm, lon, hsdSB (rB− mB−), λ(DE3)/pLys; Cmr Novagen
DH5α recA1 endA1 hsdR17 deoR thi-1 supE44 gyrA96 relA1 (lacZYA-argF ) U169 (φ80dlacZM15 ) Sambrook and Russell (2001)
K12 Wild type Tatum and Lederberg (1947)
Pseudomonas aeruginosa strains
PAO1 Wild type ATCC 15692
PAO6932 ambBT2302G (specifying AmbBS768A) This study
PAO6934 ambET3856G (specifying AmbES1286A) This study
PAO6935 ambET5455G,G5457A (specifying AmbES1819A) This study
Plasmids
pET-27b PT 7 expression vector for C-terminal His6-tagged proteins in E. coli ; Kmr Novagen
pET-28a PT 7 expression vector for N-terminal His6-tagged proteins in E. coli ; Kmr Novagen
pET-29Sfp Expression plasmid for Sfp-His6; Kmr Yin et al. (2006)
pME497 Mobilizing plasmid, Apr Voisard et al. (1988)
pME3087 Suicide vector, ColE1 replicon; Tcr Voisard et al. (1988)
pME9713 pET-28a-based expression plasmid for His6-AmbB; Kmr This study
pME9714 pET-27b-based expression plasmid for AmbE-His6; Kmr This study
pME9717 pET-27b-based expression plasmid for AmbD-His6; Kmr This study
pME9718 pET-27b-based expression plasmid for AmbC-His6; Kmr This study
pME10317 pET-27b-based expression vector for AmbES1819A-His6; Kmr This study
pME10326 pME3087 derivative for generating a S768A mutation in the thiolation domain of AmbB (replacing
codon GGT against GGC)
This study
pME10327 pET-28a-based expression plasmid for His6-AmbBS768A; Kmr This study
pME10328 pET-27b-based expression plasmid for AmbES1958A-His6; Kmr This study
pME10330 pET-27b-based expression plasmid for AmbED644A,K1230T,S1958A-His6; Kmr This study
pME10337 pET-27b-based expression plasmid for AmbES1286A-His6; Kmr This study
pME10338 pME3087 derivative for generating a S1286A mutation in the ﬁrst thiolation domain of AmbE
(replacing codonTCC against GCC)
This study
pME10341 pME3087 derivative for generating a S1819A mutation in the second thiolation domain of AmbE
(replacing codonTCG against GCA)
This study
pME9713 in which the ambB gene is fused in-frame to six his-
tidine codons at its 5′ end and expressed under the control of
the T7 promoter. To construct pME10327 (for puriﬁcation of
AmbBS768A), a 2.6-kb BamHI-EcoRI fragment with the thiola-
tion site mutation was generated by overlap extension PCR from
chromosomal DNA of PAO1 using the primer pairs XL202/XL203
and XL204/XL010. This fragment was then used to replace the
corresponding fragment in pME9713.
For construction of the ambC expression plasmid pME9718,
a 1.1-kb fragment was PCR-ampliﬁed from chromosomal DNA
of PAO1 with primers XL036 and XL044, trimmed with NdeI
and EcoRI, and cloned into pET-27b between the same sites. The
ambD expression plasmid pME9717 was made in the same way,
using primers XL034 and XL042 instead.
Plasmids for ambE expression were constructed as follows.
The ambE gene was PCR-ampliﬁed from chromosomal DNA of
PAO1 using the primer pair XL007/XL033. The resulting frag-
ment of 6.4 kb was then cloned into pET-27b between the NdeI
andNheI restriction sites. This produced pME9714 inwhich ambE
is fused in-frame to six histidine codons at its 3′end and expressed
from the T7 promoter. Variants of pME9714 with mutations in
the T1 domain (pME10337), the T2 domain (pME10317), and
the TE domain (pME10328) were constructed by overlap exten-
sion PCR using the primer pairs XL032/XL206 + XL207/XL097
(for pME10337), XL032/XL094 + XL095/XL097 (for pME10317),
and XL032/XL102 + XL101/XL097 (for pME10328), respectively.
This generated 2.6-kb fragments which were trimmed with BglII
and NheI and used to replace the corresponding fragment in
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Table 2 | Oligonucleotides (5′→3′)a.
2302Amut-1 AAGCGCGACGGTGCCACC
2302Amut-2 AGCGCGCGACGGTCGAGCGTGCCTTCGGCGGTCAGC
2302Amut-3 GCTGACCGCCGAAGGCACGCTCGACCGTCGCGCGCT
2302Amut-4 CCGGACTCGCCGGAGCGG
XL007 TCAGTCACATATGAGTGCGTCAGAAGACCTG (NdeI)
XL009 GTCAGCTAGCAGAGCGATGCAGGAGCGACA (NheI)
XL010 ACTGGAATTCCGGGGTCGTCAGGAAGCGTT (EcoRI)
XL032 ACTGAGATCTGGAAGAGCGTGCTGAAAC (BglII)
XL033 GTCAGCTAGCGGTTGCCAGGTTCGCCG (NheI)
XL034 ACTGACTCATATGAGCGCCTCGTTCAG (NdeI)
XL036 ACTGACTCATATGGAACGAACAGCTCCC (NdeI)
XL042 GTCAGAATTCTCAGTGGTGGTGGTGGTGGTGGGGTTGGTGGACAT
(EcoRI)
XL044 GTCAGAATTCTCAATGATGATGATGATGATGTGCGGCACCTCC
(EcoRI)
XL046 TCAGTCACATATG GTGGAATCCCTGGTGGCCGCGT (NdeI)
XL094 CAATTCGGCGATCGCCTGCACGCCCAGCAGTGCATGC
XL095 GCATGCACTGCTGGGCGTGC
XL097 GTCAGAATTCGCTAGCGGTTGCCAGGTTCGCCG (EcoRI, NheI)
XL101 CGCCCTGATCGGCGCCGCACTCGGCGGCATGC
XL102 GCCGCCGAGTGCGGCGCCGATCAG
XL136 CTCTTCCAGATCTCCAGCAGG (BglII)
XL137 CTTGATCGAGGACGCGAAGGAGAAC
XL138 CTCCTTCGCGTCCTCGATCAAGCAG
XL202 ACCTCCGGATCCACCGGACG (BamHI)
XL203 GCACCGCCCGCAGGGCATCGCCGCCGGCGGCGTAG
XL204 ACGCCGCCGGCGGCGATGCCCTGCGGGCGGTGCACC
XL206 CTGGATCAGGCGGATGGCGTCGCCGCCGACCTGG
XL207 CTTCCAGGTCGGCGGCGACGCCATCCGCCTGATCCAG
XL208 ACGTGGATCCTACGCCGACCTTCTCGCC (BamHI)
XL212 ACGTGGATCCGATGTGCTGCTCGGTCTCG (BamHI)
XL213 ACGTGAATTCTCCAGTCGAACGGGGTGGC (EcoRI)
aSpeciﬁed restriction sites are underlined, altered nucleotides are in bold.
pME9714. Plasmid pME10330, which carries mutations in the
the A and in the TE domain, was generated in several steps.
First, the primer pairs 2302Amut-1/2302Amut-2 and 2302A-
mut3/2302A-mut4 were used to generate the codon mutation
K1230T. The PCR fragment was then trimmed with NcoI-BglII
and used to replace the corresponding fragment in pME9714.
The resulting plasmid served as a template in a second overlap
extension PCR with XL046/XL137 and XL138/XL36 to generate a
fragment specifying the mutations K1230T and D644A. This frag-
ment was then trimmed with PstI and BglII and used to replace
the corresponding 2.6-kb fragment in the TE mutant plasmid
pME10328.
MUTANT CONSTRUCTION
Gene replacement mutants of P. aeruginosa (Table 1) were gen-
erated with suicide plasmids as described previously (Ye et al.,
1995). These were constructed as follows. To generate the suicide
plasmid pME10326 (for generation of ambBT2302G specifying
AmbBS768A), a 2.6-kb fragment was generated from pME9713
by overlap extension PCR using the primer pairs XL202/XL203
and XL204/XL010. This fragment was trimmed with BamHI
and EcoRI and cloned into pME3087 between the same sites.
For construction of the suicide plasmid pME10338 (to generate
ambET3856G specifying AmbES1286A), a 1.1-kb PCR fragment was
ampliﬁed from pME10337 with the primer pair XL212/XL213.
This fragment was trimmed with EcoRI and BamHI and cloned
into pME3087. Similarly, a 1.8-kb PCR fragment, ampliﬁed from
pME10317 with the primer pair XL097/XL208 and trimmed with
BamHI and EcoRI,was cloned into pME3087 to obtain the suicide
plasmid pME10341 (for construction of ambET5455G,G5457A speci-
fyingAmbES1819A). UsingpME497 as ahelper, the suicideplasmids
were mobilized from E. coli DH5α into P. aeruginosa PAO1 and
chromosomally integrated with selection for Tc resistance. Exci-
sion of the vector, resulting from a second crossing-over event,
was obtained by enrichment for Tc-sensitive cells. Mutant identi-
ﬁcation was done by PCR and sequence analysis. This generated
the mutants PAO6932 (the suicide plasmid used was pME10326),
PAO6934 (suicide plasmid pME10338), and PAO6935 (suicide
plasmid pME10341).
DETECTION OF AMB PRODUCTION IN P. aeruginosa STRAINS
AMB production of wildtype and mutant strains was assessed
using a previously described bioassay,which is based on the growth
inhibition of E. coli K-12 (Lee et al., 2010).
PROTEIN PURIFICATION
Hexahistidine-tagged proteins were puriﬁed from 800 ml cultures
of E. coli BL21 (DE3)/pLys (for AmbB and AmbE) or E. coli BL21
(DE3; for AmbC, AmbD, and Sfp) carrying the relevant over-
expression plasmid (see Table 1). Cultures were set up in four
Erlenmeyer ﬂasks containing 200 ml of NYB plus Km. These were
inoculated with 3 ml of precultures grown overnight in NYB con-
tainingKm(for overexpression inE. coliBL21 [DE3]) orKm+Cm
(for overexpression in E. coli BL21 [DE3]/pLys). Growth occurred
at 30◦C and 180 RPM to an OD600 of 0.4–0.5. For puriﬁcation of
AmbB andAmbE, IPTG was then added to a ﬁnal concentration of
0.5mMand incubationwas continued for another 4 h at 24◦C. For
puriﬁcation of AmbC, AmbD, and Sfp, induction was done with
1 mM IPTG and incubation was continued overnight at 20◦C.
Cells were harvested by centrifugation (8000 RPM at 4◦C for
15 min), washed once with 200 ml of resuspension buffer A
(25 mM Tris-HCl pH 7.9, 200 mM NaCl, 5 mM imidazole, and
5 mM β-mercaptoethanol), resuspended in 30 ml of the same
buffer, and lysed by two passages through a French pressure cell
press (SLM-Amicon). To avoid protein modiﬁcation and interfer-
ence with subsequent trypsin digests for MS analyses (see below),
no protease inhibitor was used. Cell debris was removed by cen-
trifugation (12’000 RPM at 4◦C for 40 min) and proteins were
puriﬁed from cell lysates by nickel chromatography using Ni-NTA
Superﬂow resin (Qiagen). 3 ml of Ni-NTA slurry was added to
the crude cell extract and the sample was rotated at 4◦C for 1 h
before loading onto a polypropylene column. Column washing
occurred with 20 ml of washing buffer (25 mM Tris-HCl pH 7.9,
200 mM NaCl, 30 mM imidazole, and 5 mM β-mercaptoethanol)
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and proteins were eluted with 10 ml of elution buffer 1 (25 mM
Tris-HCl pH 7.9, 200 mM NaCl, 100 mM imidazole, and 5 mM
β-mercaptoethanol) followed by 10 ml of elution buffer 2 (25 mM
Tris-HCl pH 7.9, 200 mM NaCl, 200 mM imidazole, and 5 mM β-
mercaptoethanol). Fractions of 1 ml were collected and analyzed
for the presence of the hexahistidine-tagged protein by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
For AmbC and AmbD, EDTA was added to each eluant fraction
to a ﬁnal concentration of 1 mM to chelate metal ions. Fractions
with pure (≥90%) hexahistidine-tagged protein were pooled and
dialyzed using a regenerated cellulose membrane (3500 molec-
ular weight cutoff, Spectra/Por, Spectrum Laboratories) against
2 lt of dialysis buffer [25 mM Tris-HCl pH 7.9, 200 mM NaCl,
10% glycerol, 0.5 mM β-mercaptoethanol (for AmbB, AmbE, and
Sfp) and 25 mM Tris-HCl pH 7.9, 200 mM NaCl, 10% glycerol
(forAmbC andAmbD)]. Proteins were subsequently concentrated
with Amicon Ultra centrifugal ﬁlters with molecular weight cut-
offs of 10’000 (for AmbC, AmbD, and Sfp) or 50’000 (for AmbB
and AmbE). Concentrated proteins (∼20 mg/ml, as determined
by Nanodrop) were ﬂash-frozen in liquid nitrogen and stored in
aliquots at −80◦C.
ATP-[32P]PYROPHOSPHATE EXCHANGE ASSAYS
ATP-[32P]pyrophosphate exchange assays were used to demon-
strate A-domain substrate speciﬁcity. Reactions were carried out
in 100 μl volumes containing 75 mM Tris-HCl (pH 7.5), 10 mM
MgCl2, 0.5 mM tris(2-carboxyethyl)phosphine (TCEP), 5 mM
ATP, 1 mM tetrasodium pyrophosphate, 1 mM of amino acid and
20 μl of tetrasodium [32P]pyrophosphate (5 mM, 2 μCi/μmol,
NEN-Perkin Elmer). Reactions were initiated by the addition
of enzyme at 1 μM and incubated at 24◦C for 2 h. At appro-
priate time points, reactions were quenched by the addition of
0.5 ml of charcoal suspension (0.1 M tetrasodium pyrophos-
phate, 0.35 M perchloric acid, 1.6% (w/v) activated charcoal).
Free [32P]pyrophosphate was removed by centrifugation and the
charcoal pellet was washed twice with wash solution (0.1 M tetra-
sodium pyrophosphate, 0.35 M perchloric acid). Charcoal-bound
radioactivity was measured in a Beckman LS 6500 scintillation
counter.
PHOSPHOPANTETHEINYLATION AND AMINOACYLATION ASSAYS
T-domain loading was assayed using an aminoacylation assay.
Apoenzymes (at 2.5 μM) were ﬁrst incubated in 75 mM Tris-
HCl pH 7.5, 5 mM MgCl2, 5 mM TCEP, 40 mM NaCl, 0.5 mM
CoA with 1.5 μM of puriﬁed promiscuous phosphopantetheinyl
transferase Sfp at 28◦C for 60 min for conversion of the apo- to the
holo-form. Subsequently, 14C-labeled substrate amino acids were
added to a ﬁnal concentration of 10 μM (L-Ala) or 50 μM (L-Glu)
and aminoacylation reactions started with the addition of ATP to
a ﬁnal concentration of 10 mM. At deﬁned time points, samples
were drawn and quenched into 800 μl of 10% (v/v) trichloroacetic
acid (TCA) and 100 μl of 1 mg/ml BSA. Precipitated proteins were
pelleted by centrifugation at 13’000 RPM for 10 min. Protein pel-
lets were washed once with 800 μl 10% TCA and ﬁnally dissolved
in 250 μl formic acid. 14C-bound radioactivity was measured by
liquid scintillation counting using a Beckman LS 6500 scintillation
counter.
GENERATION OF ENZYME-ATTACHED AMB SUBSTRATES AND
PRECURSOR PEPTIDES FOR MS ANALYSIS
Apoenzymes (at 2.5 μM) were incubated with Sfp as described
above to generate their holoforms. After 60 min, the reaction
mixture was supplemented with 10 mM ATP and 1 mM of the
substrate amino acid(s). For modiﬁcation of the growing pep-
tide chain, additional enzymes, and potential cofactors were
added at the following concentrations: 2.5 μM each of AmbC
and AmbD, 1 mM each of S-adenosylmethionine (SAM), and α-
ketoglutarate (α-KG), and 0.5 mM of ferrous iron (supplied as
[NH4]2Fe[SO4]2. Samples were incubated at 28◦C for another
2 h, supplemented with 10% glycerol, and stored at −80◦C until
analysis by MS.
For substrate identiﬁcation, holoenzymes, and ATP were incu-
bated not with a single, deﬁned amino acid but with a pool of all
20 proteinogenic amino acids (each at 0.5 mM ﬁnal concentra-
tion) or with a P. aeruginosa metabolome prepared as described
previously for E. coli (Dorrestein et al., 2006).
MS ANALYSIS
MS analyses were performed by the Protein Analysis Facility (Uni-
versity of Lausanne). Frozen protein samples were thawed and
digested by trypsin using a protocol for short digestion time (Hol-
lenhorst et al., 2010). Brieﬂy, 5 μl of proteins were digested at 30◦C
for 60 min under agitation with 281.3 ng of modiﬁed sequencing-
grade porcine trypsin (Promega) at a protein:trypsin ratio of about
10:1 (w/w) in 50 μl of 50 mM ammonium bicarbonate. Digestion
was stopped by adding 2 μl of 10% formic acid, and samples were
dried by speed-vacuum. Samples were then resuspended in 50 μl
of H2O:MeCN 97:3 (v/v) + 0.1% formic acid.
The tryptic peptide samples were analyzed by high resolution
liquid chromatography coupled with MS (LC-MS/MS) on an Ulti-
mate 3000 RSLCnano HPLC system coupled to a hybrid linear
trap LTQ-Orbitrap XL mass spectrometer (Thermo Scientiﬁc).
Solvents used were (A) H2O:MeCN 97:3 (v/v) + 0.1% formic acid
and (B) H2O:MeCN 20:80 (v/v) + 0.1% formic acid. A volume of
5 μl of sample was loaded onto a trapping microcolumn Acclaim
PepMap 100 C18 (2 cm × 100 μm, Dionex) in H2O:MeCN 97:3
(v/v) + 0.1 formic acid at a ﬂow rate of 3.5 μl/min. Peptides were
then eluted and separated on a reversed-phase Acclaim PepMap
RSLC C18 nanocolumn (75 μm ID × 15 cm, 2 μm, Dionex) or
a Nikkyo C18 nanocolumn (75 μm ID × 15 cm, 3 μm, Nikkyo
Technos) with a 95 min gradient, at a ﬂow rate of 300 nl/min.
In data-dependent acquisition controlled by Xcalibur 2.0 soft-
ware (Thermo Scientiﬁc), the eight most intense precursor ions
detected in the full MS survey performed in the Orbitrap (range
350–1700 mass/charge (m/z) ratio, resolution 60 000 at m/z 400)
were selected for fragmentation, and fragment ions were analyzed
in the ion trap. MS2 was triggered by a minimum signal threshold
of 10’000 counts and carried out at relative collision energy of 35%
(CID), with an isolation width of 4.0 amu. Only precursors with
a charge higher than one were selected for fragmentation and the
m/z of fragmented precursorswas thendynamically excluded from
any selection during 60 s. MS3 analyses were further carried out
for speciﬁc detection of phosphopantetheinylated (PPant) pep-
tides as described by Meier et al. (2011). Brieﬂy, following MS2
of the most intense precursor ion from an inclusion list, the two
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most intense fragment ions were selected for MS3 fragmentation
in the ion trap, if their mass was present in an inclusion list of
pantetheine fragments and above a signal threshold of 100 counts
in the MS/MS spectrum.
MS/MS spectra were analyzed using Mascot 2.4 (Matrix Sci-
ence, London, UK). Mascot driven search was set up against
a custom-built database containing the P. aeruginosa sequences
of wild-type and mutated AmbE and AmbB, and the sequences
of usual contaminants (enzymes, keratins, etc). Trypsin (semi-
speciﬁc cleavage at K, R, not before P) was used as the enzyme
digestion deﬁnition allowing up to two missed cleavages. Mascot
was searchedwith a parent ion tolerance of 10 ppm and a fragment
ion mass tolerance of 0.5 Da. Acetylation at protein N-terminal,
deamidation of asparagine, and glutamine, oxidation of methion-
ine, and phosphopantetheine addition to serine were speciﬁed as
variable modiﬁcations.
BIOINFORMATICS ANALYSIS
DNA and protein sequences were obtained from the P. genome
database (Winsor et al., 2011) and the protein and genome
databases available on the NCBI website1. Protein sequences
were analyzed on the polyketide synthase/NRPS analysis website
(Bachmann and Ravel, 2009) and searched against the Conserved
Domain Database using the CD-search algorithm on the NCBI
website (Marchler-Bauer and Bryant, 2004). C-domain phylo-
genetic analysis was performed using the ClustalW algorithm
(Thompson et al., 1994) available on the server of the Kyoto
University Bioinformatics Center2. Results were displayed as an
unrooted N-J phylogenetic tree (Saitou and Nei, 1987).
RESULTS
DOMAIN ARCHITECTURE OF AmbB AND AmbE
Sequence inspection of AmbB and AmbE suggested that these
enzymes are NPRSs that generate a AMB precursor peptide by
a thiotemplate mechanism (Stein et al., 1996). NRPSs can be
dissected into modules, each module being responsible for the
incorporation of one amino acid or carboxy acid into the growing
peptide chain. In turn, eachmodule consists of domains,which are
enzymatic units that catalyze the stepwise addition and modiﬁca-
tion of the amino/carboxy acid. In some cases, the biosynthesis of
a non-ribosomal peptide (NRP) can be predicted from the analysis
of these domains provided that biosynthesis follows the colinear-
ity rule (Marahiel et al., 1997). Bioinformatics analysis showed
that the AmbB protein is composed of three domains, which are
responsible for adenylation (A domain) of a substrate amino acid,
for loading of this amino acid onto a phosphopantetheine arm
attached at a conserved serine (T domain), and for condensa-
tion (C domain) of this amino acid with a second amino acid
bound at the T domain of another module (Figure 1). The mod-
ular structure of AmbE is more complex and consists of an A
domain, two T domains (T1 and T2), a C domain (indicated as
C∗ in Figure 1), a domain for methylation (MT domain) and a
domain for thioester cleavage (TEdomain). Moreover, it cannot be
ruled out that an additional domain of unknown function may be
1www.ncbi.nlm.nih.gov
2http://www.genome.jp/tools/clustalw/
located at the N-term of AmbE (Figure 1) given that this consists
of a stretch of 461 amino acids. However, no similar domain archi-
tectures have been identiﬁed in this region using the Conserved
Domains algorithm. Phylogenetic analyses of the C∗ domain sug-
gest a new or additional function of this C domain, as it does not
group with previously known L2L, D2L, epimerization, heterocy-
clization, dual condensation/epimerization, or starter C domains
(Figure S1). The C∗ domain rather groups with another atypical C
domain found in theMcyAproteinofMicrocystis aeruginosa (Tillet
et al., 2000). However, the biochemical function of McyA has not
been studied experimentally. We conclude from these analyses
that the two peptide synthetases AmbB and AmbE likely gener-
ate a tripeptide. This peptide is suspected to undergo a series of
modiﬁcation steps carried out by tailoring domains of AmbE (MT
domain, N-term domain, C∗ domain), and by the hydroxylases
AmbC and AmbD. Finally, the tripeptide would be released from
the thiotemplate by thioester cleavage (TE domain).
OVEREXPRESSION AND PURIFICATION OF THE AMB BIOSYNTHESIS
PROTEINS AmbB, AmbC, AmbD, AND AmbE
To study AMB biosynthesis with puriﬁed enzymes in vitro, the
ambBCDE genes (and their mutated derivatives, see below) were
cloned under the control of the T7 promoter in pET-28a or pET-
27b (Table 1). Proteins were puriﬁed from E. coli BL21(DE3;
for AmbC and AmbD) and BL21(DE3)/pLys (for AmbB and
AmbE) with a hexahistidine tag at their N-terminus (AmbB) or
C-terminus (AmbC,AmbD, and AmbE). According to analysis on
SDS-PAGE gels all proteins were ≥90% pure (Figure 2).
IDENTIFICATION OF L-ALA AS THE AMINO ACID SUBSTRATE OF AmbB
Based on the presence of key residues found in the A-domains
of peptide synthetases, it is often possible to predict their amino
acid speciﬁcity (Stachelhaus et al., 1998). Predictions of A domain
speciﬁcity in AmbB favors the activation of L-Ala but certain
residues of the binding pocket have also been found in D-alanine
(D-Ala) activating A domains of other peptide synthetases. We
therefore tested which of the two isomers would be activated by
AmbB using an ATP-[32P]pyrophosphate exchange reaction. In
addition, we also investigated whether other small amino acids
such as glycine (Gly) or L-serine (L-Ser) would be activated. As
shown in Figure 3A, AmbB activated preferentially L-Ala, giving
an exchange activity of 653 at 5 min already. Hower, L-Ser, Gly,
and D-Ala were activated as well, albeit to a lower extent. Exchange
activities measured at 5 min were 270, 128, and 114 for L-Ser, Gly,
and D-Ala, respectively (Figure 3A). To further speciﬁy the amino
acid substrate, we next investigated T domain loading of AmbB.
For this, proteins were incubated ﬁrst with CoA and the promis-
cuous phosphopantetheinyltransferase Sfp of Bacillus subtilis for
phosphopantetheinylation of the T domain. Loading was then
monitored by measuring the incorporation of 14C-labeled amino
acids into AmbB (and AmbBS768A, see below) by TCA precipi-
tation and liquid scintillation counting. As shown in Figure 3B,
loading of AmbB with 14C-L-Ala occurred very quickly, reaching a
maximumof 35–40% after 1min only. By contrast, no loadingwas
observed with AmbBS768A. In this protein, the active site Ser in the
conserved thiolation motif LGG(H/D)S(L/I; Stein et al., 1996) was
altered, thus preventing cofactor attachment and hence loading of
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FIGURE 2 | Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) analysis of hexahistidine-tagged proteins purified by
Ni-NTA chromatography. (A) 6% Separating gel with protein ladder (lane 1),
and AmbE (231.5 KDa, lane 2) and AmbB (137 KDa, lane 3) puriﬁed from
BL21[DE3]/pLys carrying pME9714 and pME9713, respectively. (B) 10%
Separating gel with protein ladder (lane 1), and AmbC (41.5 KDa, lane 2), and
AmbD (39.5 KDa, lane 3) puriﬁed from BL21[DE3] carrying pME9718 and
pME9717, respectively. (C) 6% Separating gels of puriﬁed mutant proteins.
Lanes 1 and 3, protein ladders; lane 2, AmbBS768A expressed from
pME10327; lane 4, AmbED644A,K1230T,S1958A expressed from pME10330;
lane 5, AmbES1958A expressed from pME10328; lane 6, AmbES1819A
expressed from pME10317; lane 7, AmbES1286A expressed from pME10337.
All proteins were puriﬁed from BL21[DE3]/pLys carrying the respective
plasmid.
L-Ala. The importance of Ser 768 of AmbB was also tested in vivo.
As expected, a P. aeruginosa strain (PAO6932) with a chromoso-
mally mutated ambB gene (specifying AmbBS768A) lost the ability
to make AMB (Figure S2).
As ATP-[32P]pyrophosphate exchange reactions had revealed
some activation of Gly and L-Ser by AmbB (Figure 3A), we tested
whether these amino acids would be loaded as well. Indeed, load-
ing was observed for both of them but to a lesser extent than with
L-Ala (Figure 3C). Taken together, we conclude that the preferred
substrate of AmbB is L-Ala and that this amino acid is loaded onto
the phosphopantetheine arm attached at Ser 768.
ACTIVATION AND LOADING OF L-GLU BY AmbE
Unlike with AmbB, an exact prediction of the amino acid sub-
strate for AmbE was not evident from the Stachelhaus motif.
As this motif predicted a polar residue, we ﬁrst considered
L-α-aminobutyrate, L-homoserine, L-aspartate, and L-threonine
as AMB precursor amino acids. However, none of these amino
acids was activated in an ATP-[32P]pyrophospate exchange assay
(data not shown). We next tested D-α-aminobutyrate, L-allo-
threonine, D-threonine, L-Glu, O-phospho-L-threonine, DL-
propargylglycine, DL-vinylglycine, and L-2-amino-4-pentenoic
acid. As shown in Figure 4A, strong activation of L-Glu
was observed. We therefore tested whether L-Glu would be
loaded onto AmbE and found that this was indeed the case
(Figure 4B). By contrast, no loading of L-Glu was observed with
the mutant AmbED644A,K1230T affected in the adenylation domain
(Figure 4C). To investigate on which of the two T domains L-Glu
would be loaded, we carried out loading assays with AmbES1286A
and AmbES1819A, two mutant proteins affected in the active site
Ser residues of the T1 and T2 domains, respectively. As shown in
Figure 4B, loading was observed with AmbES1819A but not with
AmbES1286A. To verify that both Ser residues are important for
cofactor attachment, we mutated the respective codons in the
chromosome of P. aeruginosa, giving PAO6934 and PAO6935,
respectively. As expected, both strains had lost the ability to
make AMB (Figure S2). We thus conclude that the A domain
of AmbE activates L-Glu, which is then loaded onto T1 but not
onto T2.
AmbB-DEPENDENT LOADING OF L-ALA ONTO THE T2 DOMAIN OF AmbE
The identity of the substrate loaded onto the T2 domain of AmbE
was investigated using MS-based activity screening (Dorrestein
et al., 2006; Meier et al., 2011). This method allows substrate
identiﬁcation based on the mass changes that take place during
the acylation of the T domain-attached phosphopantetheine arm
(Figure 5A). AmbE, together with AmbB (which was included in
the same experiment as an internal control), was presented either
with a mixture of all 20 natural amino acids or with a P. aeruginosa
metabolome before being digested with trypsin and analyzed by
LC-MS/MS (see Section“Materials andMethods”for experimental
details). Similar results were obtained in both cases. The phospho-
pantetheinylated AmbB peptide AGQGFYAAGGDSLR presented
a mass shift of +71.04 indicative of Ala loading onto the T site
of AmbB (Figure 5B; Table 3). In agreement with the pro-
tein’s previously observed substrate promiscuity, the same peptide
also showed mass shifts characteristic for loading of Gly (57.02;
Figure S3A; Table 3) and Ser (87.03; Figure S3B; Table 3). To
identify the substrates loaded onto AmbE, mass shifts of the phos-
phopantetheinylated peptides RPAIGVSDNFFQVGGDSIR (T1
domain) and VLGRPLAADQGFASAGGHSLLGVQAIAELR (T2
domain) were analyzed. As expected, we found a Glu-speciﬁc
mass shift of +129.04 for the T1-speciﬁc peptide (Figure S4A;
Table 3). For the T2-speciﬁc peptide we detected a mass shift
of +71.04 (Figure S4B; Table 3), indicating that the substrate
amino acid loaded at the second T domain of AmbE could be
Ala.
The potential identity of the T2-attached substrate with Ala
suggested that this amino acid may have been loaded in trans from
AmbB. This hypothesis was tested using the AmbBS768A mutant
protein which is able to activate L-Ala but cannot load it onto its
own T domain (see Figure 3B). As shown in Figure 6, the presence
of AmbBS768A in an aminoacylation assay of AmbE allowed 14C-L-
Ala to be loaded, reaching a maximum of over 60% labeled protein
after 30 min. By contrast, no loading was observed in the absence
of AmbBS768A or when AmbE was replaced by the T2 domain
mutant AmbES1819A. We thus conclude that AmbB loads L-Ala in
cis onto its own T domain and in trans onto the T2 domain of
AmbE.
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FIGURE 3 | Identification of L-Ala as the preferred amino acid substrate
activated by and loaded onto AmbB. (A) AmbB activation of L-Ala
(diamonds), D-Ala (triangles), Gly (rectangles), and L-Ser (circles). AmbB
was incubated sequentially with each amino acid in an ATP-[32P]
pyrophosphate exchange assay. At different time points, generated ATP
(formed by the reverse reaction of the AmbB A domain in the presence of
[32P] pyrophosphate) was bound and counted. ATP-PPi exchange activity
was determined for the full course of the assay and is expressed as the
amount of conversion (one being 100% conversion) multiplied by the molar
ratio of PPi to AmbB. (B) Loading of
14C-L-Ala onto AmbB (ﬁlled diamonds)
and AmbBS768A (empty diamonds). Proteins were incubated with
radiolabeled L-Ala in an aminoacylation assay. At several time points,
proteins (with bound amino acids) were precipitated and radioactivity was
counted. Percentage of loading was determined using the molar ratio of
bound radioactivity to the amount of protein in the assay. (C) Loading of
L-Ala, Gly, and L-Ser onto AmbB. AmbB was sequentially incubated with
14C-L-Ala (diamonds), 14C-Gly (rectangles), and 14C-L-Ser (circles) in an
aminoacylation assay. At several time points, AmbB (with bound amino
acids) was precipitated and radioactivity was counted. Percentage of
loading was determined using the molar ratio of bound radioactivity to the
amount of protein in the assay.
FIGURE 4 | Identification of L-Glu as the amino acid substrate activated
by AmbE and loaded onto itsT1 domain. (A) End-point ATP-[32P]
pyrophosphate exchange assay to screen potential AmbE substrates. At
120 min, generated ATP (formed by the reverse reaction of the A domain of
AmbE in the presence of [32P] pyrophosphate) was bound and counted.
ATP-PPi exchange activity is expressed as the amount of conversion (one
being 100% conversion) multiplied by the molar ratio of PPi to AmbE.
(B) Loading of 14C-L-Glu onto AmbE (ﬁlled diamonds), AmbES1286A (empty
rectangles), and AmbES1819A (empty circles). Proteins were incubated with
the radiolabeled amino acid in an aminoacylation assay. At several time
points, proteins (with bound amino acids) were precipitated and
radioactivity was counted. Percentage of loading was determined using the
molar ratio of bound radioactivity to the amount of protein in the assay.
(C) Mutations in the A domain of AmbE abolish protein loading with L-Glu.
AmbES1958A (ﬁlled diamonds), and AmbED644A,K1230T,S1958A (empty
diamonds) were incubated with 14C-L-Glu in an aminoacylation assay. At
several time points, proteins (with bound amino acids) were precipitated
and radioactivity was counted. Percentage of loading was determined
using the molar ratio of bound radioactivity to the amount of protein in the
assay. Note that the mutation of the active site Ser (S1958) of theTE
domain does not interfere with loading of L-Glu. By contrast, amino acid
alterations in the A domain (D644A and K1230T) abolished loading entirely.
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FIGURE 5 | Identification of AmbB/AmbE-bound substrates and pathway
intermediates by phosphopantetheinyl elimination reactions.
(A) Structure of PPant ejection ions after MS2 fragmentation and
pantetheine-speciﬁc MS3 pattern (adapted from Meluzzi et al., 2008; Meier
et al., 2011). Diagnostic m/z values obtained in B and C are underlined.
(B) Identiﬁcation of Ala on AmbB by characteristic MS2 and MS3 spectra.
AmbB and AmbE (at 2.5 μM; converted to their holo-forms by Sfp) were
incubated with 0.5 mM of all 20 proteinogenic amino acids before trypsin
digestion and analysis by MS. (C) Identiﬁcation of Ala-AMB-Ala on AmbE by
characteristic MS2 and MS3 spectra. The assay contained AmbB, AmbC,
AmbD, and AmbES1958A (at 2.5 μM; the two NRPSs were converted to their
holo-forms by Sfp), L-Ala and L-Glu (at 1 mM), as well as the cofactors SAM,
α–KG (at 1 mM) and ferrous iron (at 0.5 mM). After incubation, the sample
was treated with trypsin and analyzed by MS.
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Table 3 | AmbB andAmbE peptides with AMB substrates and pathway intermediates loaded via phosphopantetheine.
Peptidea Substrate or pathway
intermediate X loaded
(theoretical mass)
Theoretical m/z
(z) (monoisotopic
mass)
Observed m/z
(m ppm)
m/z pant-X Amb enzymes required for
detection of attached compound
AGQGFYAAGGDSLR
(AmbB, T domain)
Gly (57.021)
Ala (71.037)
Ser (87.032)
883.883 (2)
890.891 (2)
898.889 (2)
883.881 (−2.3)
890.890 (−1.1)
898.886 (−3.3)
318.1
332.2
348.2
AmbB
AmbB
AmbB
RPAIGVSDNFFQVGGDSIR
(AmbE, T1 domain)
Glu (129.043)
Glu-Ala (200.080)
835.392 (3)
859.071 (3)
835.393 (1.2)
859.072 (1.2)
390.2
461.2
AmbE/AmbES1819Ab
AmbB+AmbES1819Ab
VLGRPLAADQGFASAG
GHSLLGVQAIAELR
(AmbE, T2 domain)
Ala (71.037)
Ala-AMB-Ala (255.121)
Ala-Glu-Ala (271.117)
847.192 (4)
893.212 (4)
897.211 (4)
847.189 (−3.5)
893.210 (−2.2)
897.213 (−2.2)
332.2
516.2
532.2
AmbB+AmbE/AmbES1819Ab
AmbB+AmbC+AmbD+AmbES1819Ab
AmbB+AmbES1819Ab
aPeptides were generated by trypsin digestion of reaction mixtures containing the indicated Amb enzymes. bFor increased detection of enzyme-attached compounds,
the thioesterase-negative mutant protein AmbES1819A was used in certain experiments.The Ser residues carrying phosphopantetheine-linked substrates and pathway
intermediates are underlined.
FIGURE 6 | AmbB-dependent loading of L-Ala onto theT2 domain of
AmbE. AmbE (ﬁlled squares), AmbE + AmbBS768A (ﬁlled circles), and
AmbES1819A+ AmbBS768A (ﬁlled diamonds) were incubated with 14C-L-Ala
in an aminoacylation assay. At several time points, proteins (with bound
amino acids) were precipitated and radioactivity was counted. Percentage
of loading was determined using the molar ratio of bound radioactivity to
the amount of AmbE/AmbES1819A in the assay.
ASSEMBLY OF A TRIPEPTIDE AMB PRECURSOR ON AmbE
The identiﬁcation of the substrate amino acids activated by and
loaded ontoAmbB andAmbE suggested that these proteins gener-
ate an L-Ala-L-Glu-L-Ala tripeptide. We speculated that the central
L-Glu would be the amino acid to be converted to AMB by AmbC,
AmbD, and tailoring domains of AmbE, while the two ﬂanking
L-Ala residues may function as protective groups during these
modiﬁcations. Indeed, LC-MS/MS analysis of in vitro reactions
carried out with different enzyme combinations, revealed several
characteristic mass shifts of the phosphopantetheinylated T1 and
T2 peptides of AmbE (Table 3). A reaction mixture containing
AmbB, AmbES1958A (a thioesterase-negative AmbE variant used
to stabilize enzyme-attached AMB precursor peptides), L-Ala and
L-Glu, generated not only the previously observed mass shifts of
the phosphopantetheinylated amino acid substrates [+129.04 for
Glu and +71.04 for Ala; data not shown), but also mass shifts of
+200.08 (at T1) and+271.12 (at T2; Figures S5A,B]. Thesemasses
are identical with those expected for a T1-attached Glu-Ala dipep-
tide and for a T2-attached Ala-Glu-Ala tripeptide, respectively.
When the two oxygenases (AmbC and AmbD), their cofactors (α-
ketoglutarate and ferrous iron), and SAM (cofactor for the MT
domain of AmbE) were included in the assay, the mass shifts of
these pathway intermediates were no longer detected. Instead, a
new mass shift of +255.12 was identiﬁed for the T2-speciﬁc pep-
tide (Figure 5C). This mass corresponds to that expected for an
Ala-AMB-Ala tripeptide.
DISCUSSION
In this work we have demonstrated that L-Ala and L-Glu are the
amino acid substrates for AMB production. The identity of these
building blocks was demonstrated with classical aminoacylation
assays using radiolabeled amino acid substrates and also with a
MS-based approach which detected these amino acids bound via
phosphopantetheinyl arms to the T domains of AmbB and AmbE
(see Figure 7). Speciﬁcally, we detected L-Ala bound to the T
domain of AmbB (Figures 3 and 5B) and to the T2 domain of
AmbE (Figures 6 and S4B) while L-Glu was bound to the thiola-
tion domain T1 of AmbE (Figures 4B and S4A). However, AmbE
speciﬁes a single adenylation domain, which was predicted to acti-
vate a polar amino acid such as L-Glu. Indeed, L-Glu was no longer
loaded onto T1 when this domain was mutated (Figure 4C), most
likely because the mutations had interfered with L-Glu activation.
How is L-Ala bound at the AmbE’s T2 site activated? As L-Ala was
identiﬁed as the substrate activated by and loaded onto AmbB we
hypothesized that AmbB might also be responsible for loading the
T2 site of AmbE. Using an AmbB mutant unable to load its own T
site we demonstrated that this was indeed the case (Figure 6).
The identiﬁcation of three amino acids as the building blocks
required for AMB generation is remarkable as AMB has not
been found as a tripeptide but as a single non-proteinogenic
amino acid with a molecular weight of 131.06 Da (Figure 7).
To further investigate this novel biosynthesis we searched for
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FIGURE 7 | Proposed model for AMB biosynthesis with indication of
mass shifts (in Da) of tethered molecules.The A domain of AmbB activates
L-Ala (residue shown in red) and loads it onto its ownT domain (step 1a) and
onto theT2 domain of AmbE (step 1b). The A domain of AmbE activates L-Glu
(residue shown in blue) and loads it onto its T1 domain (step 2). Then, the C
domain of AmbB or the C* domain of AmbE would condense L-Ala with L-Glu
onto theT1 domain of AmbE forming the L-Glu-L-Ala dipeptide (step 3). This
would subsequently be condensed with L-Ala on theT2 domain of AmbE to
give the tripeptide L-Ala-L-Glu-L-Ala (step 4). Modiﬁcation of the central L-Glu
by action of AmbC, AmbD, the MT domain of AmbE, and eventually by the C*
domain and/or by the N-term of AmbE, would give rise to the tripeptide
L-Ala-AMB-L-Ala (step 5). This is believed to be the ﬁnal peptide released from
AmbE by action of theTE domain (step 6). Finally, the ﬂanking L-Ala residues
are removed by a processing step to yield AMB (step 6).
pathway intermediates attached at the thiolation sites of AmbE
and found a Glu-Ala dipeptide and an Ala-Glu-Ala tripeptide at
T1 and T2, respectively (Figure S5). These compounds were no
longer detected when the assay contained, in addition, the oxy-
genases AmbC and AmbD together with all cofactors. Instead,
large amounts of an Ala-AMB-Ala tripeptide attached at T2
were detected (Figure 5C). Based on these results we propose
a biosynthetic pathway for AMB production which proceeds via
the generation of a tripeptide precursor. According to this model
(Figure 7), the A domain of AmbB activates L-Ala which is loaded
onto the protein’s own T domain and onto the T2 domain of
AmbE. The A domain of AmbE activates L-Glu, which is loaded
onto the T1 domain. The C domain of AmbB then condenses
L-Ala and L-Glu to form the L-Glu-L-Ala dipeptide at T1 of
AmbE. This dipeptide is subsequently condensed, probably by
the C∗ domain, with the L-Ala residue attached at T2 to give
the L-Ala-L-Glu-L-Ala tripetide at T2. The central amino acid,
L-Glu, would then undergo a series of modiﬁcations to be con-
verted into AMB while the two ﬂanking L-Ala residues remain
in place. The modiﬁcations of L-Glu would be carried out by
AmbC, AmbD, and tailoring domains of AmbE (Figure 1). The
order and the timing of these modiﬁcations is currently unknown
and we cannot exclude at this point that some modiﬁcations of
L-Glu may occur even before condensation with the two L-Ala
residues, as the unmodiﬁed di- and tripeptides (L-Ala-L-Glu and
L-Ala-L-Glu-L-Ala) were observed only in the absence of AmbC
and AmbD. Finally, the L-Ala-AMB-L-Ala tripeptide is released by
thioester cleavage (TE domain of AmbE) and processed to give
AMB and two molecules of L-Ala.
What is the role of the two ﬂanking L-Ala residues during
biosynthesis of AMB? As previously mentioned, AMB inhibits
PLP-dependent enzymes (Berkowitz et al., 2006) and as such could
act as a growth inhibitor in the producer as well. We thus spec-
ulate that the two ﬂanking L-Ala residues could not only act as
protective groups during the conversion of L-Glu to AMB, but
also have the additional function of preventing AMB toxicity
during biosynthesis. It is not yet clear how processing of the
Ala-AMB-Ala tripeptide occurs. We believe that the processing
peptidase is encoded by P. aeruginosa itself as free AMB is read-
ily detected in P. aeruginosa culture supernatants (Scannell et al.,
1972; Lee et al., 2010). However, we cannot exclude that the Ala-
AMB-Ala peptide is also excreted by P. aeruginosa, taken up by
susceptible neighbors and subjected to peptidase/amidase action
to liberate the toxin. Such a “Trojan Horse” mechanism has been
described previously for other bacterial toxins such as the herbi-
cide phosphinothricin (PT), which is produced non-ribosomally
by Streptomyces viridochromogens as an PT-Ala-Ala tripeptide
(Metcalf and van der Donk, 2009).
Secretion of AMB (and/or its precursor tripeptide) is expected
to be carried out by AmbA, a member of the LysE transporter
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family (Lee et al., 2010). However given that LysE is an amino
acid transporter (Vrljic et al., 1996), there is a higher likelihood
that AmbA exports AMB. We speculate that AmbA could also be
crucial for resistance of the producer bacterium when free AMB
re-enters the cytoplasm. As for AMB import into P. aeruginosa, it
is not clear which transporter is involved, but it is interesting to
note that in Staphylococcus aureus a mutation in a D-methionine
transport system rendered this bacterium resistant toward AMB
(our unpublished observations).
AMB is the ﬁrst oxyvinylglycine made from L-Glu. In other
cases, e.g., 4-AVG (Fernández et al., 2004), 4-FVG (Halgren et al.,
2013), and rhizobitoxine (Mitchell and Coddington, 1991; Yasuta
et al., 2001), the starting amino acid appears to be homoserine.
Moreover, there is no evidence that these compounds are made by
a thiotemplate mechanism, or processed from a precursor peptide,
suggesting that there is signiﬁcant diversity in the biosynthesis of
oxyvinylglycines.
In summary, we have elucidated here the ﬁrst steps of the AMB
biosynthetic pathway. Clearly, these data conﬁrm our previous
results, which showed that the amb gene cluster is responsible for
the biosynthesis of AMB (Lee et al., 2010, 2013a) and does not
specify the quorum-sensing molecule IQS [2-(2-hydroxyphenyl)-
thiazole-4-carbaldehyde], as reported by the group of Lian-Hui
Zhang (Lee et al., 2013b). The chemical structure of IQS indicates
that this compound may be assembled from salicylate and cys-
teine. However, neither of the two peptide synthetases encoded
by the amb gene cluster present adenylation domains with a
speciﬁcity for these substrates and the biochemical assays per-
formed in this work show that AmbB is loaded with alanine
while AmbE is loaded with glutamate and alanine. It is thus
highly implausible that IQS is speciﬁed by the amb gene cluster.
Unfortunately, the authors of the IQS publication did not verify
which molecule was produced in an E. coli strain overexpressing
ambBCDE. Moreover, their biotest used to measure AMB pro-
duction was not performed as should be (Lee et al., 2010) which
caused a misinterpretation of the results. As proposed recently
by Ye et al. (2014), IQS – which is actually aeruginaldehyde –
seems instead to be a byproduct produced from salicylate cou-
pled to the ﬁrst moiety of cysteine during biosynthesis of the
enantiomeric siderophores pyochelin and enantiopyochelin in P.
aeruginosa and P. ﬂuorescens, respectively (reviewed by Youard
et al., 2011).
Many questions concerning the biosynthesis and transport of
AMB remain open. It will be fascinating to dissect the function
of the tailoring enzymes, to determine the order in which the
modiﬁcations of L-Glu occur, to identify the processing enzyme,
and to investigate the role of AmbA inAMB export and immunity.
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